The Risk of Severe Infections Following Rituximab Administration in Patients With Autoimmune Kidney Diseases
Balazs Odler,
Martin Windpessl,
Marcell Krall,
Maria Steiner,
Regina Riedl,
Carina Hebesberger,
Martin Ursli,
Emanuel Zitt,
Karl Lhotta,
Marlies Antlanger,
Daniel Cejka,
Philipp Gauckler,
Martin Wiesholzer,
Marcus Saemann,
Alexander R Rosenkranz,
Kathrin Eller,
Andreas Kronbichler
Nov 22, 2021
OBJECTIVE: To characterize the incidence, type, and risk factors of severe infections (SI) in patients with autoimmune kidney diseases treated with rituximab (RTX). METHODS: We conducted a multicenter retrospective cohort study...